Systemic Immunomodulatory Effects and Pharmacogenetics of Atorvastatin in Early Atherosclerosis

PHASE4CompletedINTERVENTIONAL
Enrollment

108

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

December 31, 2008

Study Completion Date

January 31, 2009

Conditions
Inflammation
Interventions
DRUG

Atorvastatin

atorvastatin 80mg tablets given by mouth once daily for 16 weeks with follow-up visits every 4 weeks

Trial Locations (1)

32610

University of Florida, Gainesville

All Listed Sponsors
collaborator

American Heart Association

OTHER

collaborator

American College of Clinical Pharmacy

OTHER

lead

University of Florida

OTHER

NCT00361283 - Systemic Immunomodulatory Effects and Pharmacogenetics of Atorvastatin in Early Atherosclerosis | Biotech Hunter | Biotech Hunter